5 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more
Peter Salzmann
Kura Oncology
19 followers
SpringWorks Therapeutics
6 followers
REVOLUTION Medicines
5 followers
MindMed
4 followers
Stemline Therapeutics
3 followers
Prime Medicine
3 followers
4D Molecular Therapeutics
3 followers
CytomX
3 followers
Celularity
3 followers
Pivot Bio
2 followers
Tenaya Therapeutics
2 followers
Explore companies